Guanglei Zhuang

8PUBLICATIONS
46CO-AUTHORS
Molecular targetsInnate immunityNeural engineeringPredictive and prognostic markersComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 28, 2024
YY1 downregulation underlies therapeutic response to molecular targeted agents.

Shichao Zhou, Jingyu Zang, Mei-Chun Cai

|Sep 03, 2024
Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer.

Jingyu Zang, Akezhouli Shahatiaili, Mei-Chun Cai

|Nov 22, 2023
Therapeutic targeting of CPSF3-dependent transcriptional termination in ovarian cancer.

Peiye Shen, Kaiyan Ye, Huaijiang Xiang

|Aug 03, 2023
Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer.

Ruiyun Zhang, Jingyu Zang, Di Jin

|Sep 28, 2022
Transient targeting of BIM-dependent adaptive MCL1 preservation enhances tumor response to molecular therapeutics in non-small cell lung cancer.

Kaixuan Shi, Haijiao Lu, Zhenfeng Zhang

|Feb 06, 2022
SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer.

Lifeng Lin, Kaixuan Shi, Shaoqing Zhou

Pageof 2

Frequent Collaborators

2 joint publications

Xiaojing Zhao

2 joint publications

Zhuang Yu

2 joint publications

Ruiyun Zhang

2 joint publications

Jingyu Zang